Form 4: Repligen Corp Director Karen A. Dawes Executes Stock Option and Sells Shares
SEC Form 4 Filing
Director Karen A. Dawes exercised stock options and sold a portion of the acquired shares of Repligen Corp on February 27, 2024.
Summary
- On February 27, 2024, Karen A. Dawes, a director of Repligen Corp, exercised stock options to acquire 4,626 shares of common stock at a price of $42.07 per share.
- Following the exercise of the options, Ms. Dawes sold 1,000 shares of Repligen Corp common stock at a price of $193.35 per share.
- After these transactions, Ms. Dawes beneficially owns 87,367 shares of Repligen Corp common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- Shareholders are informed about the trading activities of a company director, providing transparency.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of stock option exercise and share sale. |
| 02/28/2024 | Date of signature on the Form 4 filing. |
| 05/16/2028 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.